Does HRCT Pattern Influence the Effect of Nintedanib in Patients with Progressive Fibrosing Interstitial Lung Diseases?

被引：0

作者：

Brown, K. K. ^{[1
]}

Walsh, S. L. F. ^{[2
]}

Devaraj, A. ^{[3
]}

Song, J. ^{[4
]}

Wuyts, W. A. ^{[5
]}

Valenzuela, C. ^{[6
]}

Goeldner, R. ^{[7
]}

Stowasser, S. ^{[8
]}

Schlenker-Herceg, R. ^{[9
]}

Wells, A. U. ^{[2
,10
]}

机构：

[1] Natl Jewish Hlth, Pulm Crit Care & Sleep Med, Denver, CO USA

[2] Imperial Coll, Natl Heart & Lung Inst, London, England

[3] Royal Brompton & Harefield NHS Fdn Trust, Dept Radiol, London, England

[4] Univ Ulsan, Asan Med Ctr, Pulm & Crit Care Med, Coll Med, Seoul, South Korea

[5] Univ Hosp Leuven, Dept Resp Med, Unit Interstitial Lung Dis, Leuven, Belgium

[6] Hosp Univ La Princesa, Madrid, Spain

[7] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany

[8] Boehringer Ingelheim Int GmbH, Ingelheim, Germany

[9] Boehringer Ingelheim Pharmaceut Inc, 90 E Ridge POB 368, Ridgefield, CT 06877 USA

[10] Royal Brompton & Harefield NHS Fdn, Natl Inst Hlth Res Resp Biomed Res Unit, London, England

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2020年 / 201卷

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

A1507

引用

页数：2

共 50 条

[1] Does HRCT pattern influence the effect of nintedanib in patients with progressive fibrosing interstitial lung diseases?
Behr, J.
Brown, K. K.
Walsh, S. L. F.
Devaraj, A.
Song, J. W.
Wuyts, W. A.
Valenzuela, C.
Goeldner, R. G.
Stowasser, S.
Schlenker-Herceg, R.
Wells, A. U.
PNEUMOLOGIE, 2021, 75 : S31 - S32
[2] Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
Kao, Jui-Hung
Huang, Hsin-Tuan
Li, Ko-Jen
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (08): : 780 - 781
[3] Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
Flaherty, K. R.
Wells, A. U.
Cottin, V
Devaraj, A.
Walsh, S. L. F.
Inoue, Y.
Richeldi, L.
Kolb, M.
Tetzlaff, K.
Stowasser, S.
Coeck, C.
Clerisme-Beaty, E.
Rosenstock, B.
Quaresma, M.
Haeufel, T.
Goeldner, R-G
Schlenker-Herceg, R.
Brown, K. K.
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (18): : 1718 - 1727
[4] Nintedanib in progressive fibrosing interstitial lung diseases
Hadjiski, D.
ZEITSCHRIFT FUR RHEUMATOLOGIE, 2020, 79 (04): : 393 - 394
[5] Nintedanib in Progressive Fibrosing Interstitial Lung Diseases Reply
Flaherty, Kevin R.
Wells, Athol U.
Brown, Kevin K.
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (08): : 781 - 781
[6] Nintedanib for treating progressive fibrosing interstitial lung diseases
Adler, Amanda, I
Guo, Yelan
Thiam, Aminata
Elliott, Nicole
Patel, Sanjeev
LANCET RESPIRATORY MEDICINE, 2021, 9 (12): : E116 - E117
[7] Effects of Nintedanib in Patients with Progressive Fibrosing Autoimmune Disease-related Interstitial Lung Diseases (ILDs) in the INBUILD Trial: Subgroups by HRCT Pattern
Dellaripa, Paul
Aringer, Martin
Mann-Vold, Anna Maria Hoff
Kelly, Clive
Mittoo, Shikha
James, Alexandra
Rohr, Klaus
Stowasser, Susanne
Inoue, Yoshikazu
ARTHRITIS & RHEUMATOLOGY, 2020, 72
[8] Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases
Vincent Cottin
Luca Richeldi
Ivan Rosas
Maria Otaola
Jin Woo Song
Sara Tomassetti
Marlies Wijsenbeek
Manuela Schmitz
Carl Coeck
Susanne Stowasser
Rozsa Schlenker-Herceg
Martin Kolb
Respiratory Research, 22
[9] Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases
Cottin, Vincent
Richeldi, Luca
Rosas, Ivan
Otaola, Maria
Song, Jin Woo
Tomassetti, Sara
Wijsenbeek, Marlies
Schmitz, Manuela
Coeck, Carl
Stowasser, Susanne
Schlenker-Herceg, Rozsa
Kolb, Martin
RESPIRATORY RESEARCH, 2021, 22 (01)
[10] Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases
Wollin, Lutz
Distler, Joerg H. W.
Redente, Elizabeth F.
Riches, David W. H.
Stowasser, Susanne
Schlenker-Herceg, Rozsa
Maher, Toby M.
Kolb, Martin
EUROPEAN RESPIRATORY JOURNAL, 2019, 54 (03)

← 1 2 3 4 5 →